Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2011-004951-38-IT
EUCTR2011-004951-38-IT
Active, not recruiting
Not Applicable

Role of PET/CT with 18F-choline in biochemical relapse in prostate cancer patients treated with radical intent. Pet Col study. - Pet-Col

AZIENDA USL DI FORLI'0 sitesDecember 22, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsprostate cancer patientsMedDRA version: 14.1Level: PTClassification code 10036911Term: Prostate cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
prostate cancer patients
Sponsor
AZIENDA USL DI FORLI'
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 22, 2011
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Male

Investigators

Sponsor
AZIENDA USL DI FORLI'

Eligibility Criteria

Inclusion Criteria

  • •\- previous prostate cancer radically treated \- PSA\>1 ng/ml with an increase of at least 20% in the last 3\-6 months \- \=18 years \- written informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range: 0
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 40
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 60

Exclusion Criteria

  • •\- PSA\<1 ng/ml \- psichiatric disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Role of PET/ CT with 18F-fluorocholine in the staging of patients with intermediate/high risk prostate cancer.
EUCTR2013-002511-99-ITISTITUTO ONCOLOGICO VENETO390
Active, not recruiting
Phase 1
Prospective comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the initial work-up of Multiple MyelomaMultiple myelomaMedDRA version: 20.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2018-003926-10-FRCHU de Bordeaux30
Completed
Not Applicable
Diagnostic Value of 18F-Choline PET/CT in Patients With a Thyroid Nodule With an Indeterminate Cytology: Pilot StudyThyroid Gland
NCT02784223Centre Francois Baclesse107
Active, not recruiting
Not Applicable
study for evaluation of 18F-choline PET/CT efficacy in patients with prostate carcinoma. - ND
EUCTR2010-021501-20-ITISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED
Withdrawn
Not Applicable
Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBMAstrocytoma, Grade IVGiant Cell GlioblastomaGlioblastoma Multiforme
NCT00943462Centre hospitalier de l'Université de Montréal (CHUM)